Literature DB >> 11747718

Trichomonas vaginalis, HIV, and African-Americans.

F Sorvillo1, L Smith, P Kerndt, L Ash.   

Abstract

Trichomonas vaginalis may be emerging as one of the most important cofactors in amplifying HIV transmission, particularly in African-American communities of the United States. In a person co-infected with HIV, the pathology induced by T. vaginalis infection can increase HIV shedding. Trichomonas infection may also act to expand the portal of entry for HIV in an HIV-negative person. Studies from Africa have suggested that T. vaginalis infection may increase the rate of HIV transmission by approximately twofold. Available data indicate that T. vaginalis is highly prevalent among African-Americans in major urban centers of the United States and is often the most common sexually transmitted infection in black women. Even if T. vaginalis increases the risk of HIV transmission by a small amount, this could translate into an important amplifying effect since Trichomonas is so common. Substantial HIV transmission may be attributable to T. vaginalis in African-American communities of the United States.

Entities:  

Mesh:

Year:  2001        PMID: 11747718      PMCID: PMC2631893          DOI: 10.3201/eid0706.010603

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  50 in total

1.  Incidence and predictors of reinfection with Trichomonas vaginalis in HIV-infected women.

Authors:  L M Niccolai; J J Kopicko; A Kassie; H Petros; R A Clark; P Kissinger
Journal:  Sex Transm Dis       Date:  2000-05       Impact factor: 2.830

2.  18S ribosomal DNA-based PCR for diagnosis of Trichomonas vaginalis.

Authors:  H Mayta; R H Gilman; M M Calderon; A Gottlieb; G Soto; I Tuero; S Sanchez; A Vivar
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

3.  Trichomonas and yeast vaginitis in institutionalized adolescent girls.

Authors:  H W Ris; R W Dodge
Journal:  Am J Dis Child       Date:  1973-02

4.  A biomathematical model for prevalence of Trichomonas vaginalis.

Authors:  J Ipsen; P Feigl
Journal:  Am J Epidemiol       Date:  1970-02       Impact factor: 4.897

5.  Comparative prevalence of infection with Trichomonas vaginalis among men attending a sexually transmitted diseases clinic.

Authors:  J L Joyner; J M Douglas; S Ragsdale; M Foster; F N Judson
Journal:  Sex Transm Dis       Date:  2000-04       Impact factor: 2.830

6.  Improved diagnosis of Trichomonas vaginalis infection by PCR using vaginal swabs and urine specimens compared to diagnosis by wet mount microscopy, culture, and fluorescent staining.

Authors:  C van Der Schee; A van Belkum; L Zwijgers; E van Der Brugge; E L O'neill; A Luijendijk; T van Rijsoort-Vos; W I van Der Meijden; H Verbrugh; H J Sluiters
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

7.  A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis.

Authors:  W Wiese; S R Patel; S C Patel; C A Ohl; C A Estrada
Journal:  Am J Med       Date:  2000-03       Impact factor: 4.965

8.  Vaginitis in sexually active women: relationship to nine sexually transmitted organisms.

Authors:  N G Osborne; L Grubin; L Pratson
Journal:  Am J Obstet Gynecol       Date:  1982-04-15       Impact factor: 8.661

9.  Trichomonas vaginalis: reevaluation of its clinical presentation and laboratory diagnosis.

Authors:  A C Fouts; S J Kraus
Journal:  J Infect Dis       Date:  1980-02       Impact factor: 5.226

10.  Sexually transmitted conditions among women college students.

Authors:  W M McCormack; J R Evrard; C F Laughlin; B Rosner; S Alpert; V A Crockett; D McComb; S H Zinner
Journal:  Am J Obstet Gynecol       Date:  1981-01-15       Impact factor: 8.661

View more
  93 in total

1.  The influence of bacterial vaginosis on the response to Trichomonas vaginalis treatment among HIV-infected women.

Authors:  Megan Gatski; David H Martin; Judy Levison; Leandro Mena; Rebecca A Clark; Mary Murphy; Harold Henderson; Norine Schmidt; Patricia Kissinger
Journal:  Sex Transm Infect       Date:  2011-01-29       Impact factor: 3.519

2.  Patient-delivered partner treatment and Trichomonas vaginalis repeat infection among human immunodeficiency virus-infected women.

Authors:  Megan Gatski; Leandro Mena; Judy Levison; Rebecca A Clark; Harold Henderson; Norine Schmidt; Susan L Rosenthal; David H Martin; Patricia Kissinger
Journal:  Sex Transm Dis       Date:  2010-08       Impact factor: 2.830

3.  A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women.

Authors:  Patricia Kissinger; Leandro Mena; Judy Levison; Rebecca A Clark; Megan Gatski; Harold Henderson; Norine Schmidt; Susan L Rosenthal; Leann Myers; David H Martin
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12-15       Impact factor: 3.731

4.  Comparison between the Gen-Probe transcription-mediated amplification Trichomonas vaginalis research assay and real-time PCR for Trichomonas vaginalis detection using a Roche LightCycler instrument with female self-obtained vaginal swab samples and male urine samples.

Authors:  Andrew Hardick; Justin Hardick; Billie Jo Wood; Charlotte Gaydos
Journal:  J Clin Microbiol       Date:  2006-08-30       Impact factor: 5.948

5.  Molecular dynamics simulations of Trichomonas vaginalis ferredoxin show a loop-cap transition.

Authors:  Tiffany E Weksberg; Gillian C Lynch; Kurt L Krause; B Montgomery Pettitt
Journal:  Biophys J       Date:  2007-02-26       Impact factor: 4.033

6.  5-Nitroimidazole drugs effective against metronidazole-resistant Trichomonas vaginalis and Giardia duodenalis.

Authors:  Jacqueline A Upcroft; Linda A Dunn; Janelle M Wright; Kamel Benakli; Peter Upcroft; Patrice Vanelle
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

7.  Trichomonas vaginalis infection: can we afford to do nothing?

Authors:  R Scott McClelland
Journal:  J Infect Dis       Date:  2008-02-15       Impact factor: 5.226

8.  COMPARISON OF PERMANENT STAINING METHODS FOR THE LABORATORY DIAGNOSIS OF TRICHOMONIASIS.

Authors:  Camila Braz Menezes; Mariana dos Santos Mello; Tiana Tasca
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-02-23       Impact factor: 1.846

9.  Probiotic Properties of Lactobacillus crispatus 2,029: Homeostatic Interaction with Cervicovaginal Epithelial Cells and Antagonistic Activity to Genitourinary Pathogens.

Authors:  Vyacheslav Abramov; Valentin Khlebnikov; Igor Kosarev; Guldana Bairamova; Raisa Vasilenko; Natalia Suzina; Andrey Machulin; Vadim Sakulin; Natalia Kulikova; Nadezhda Vasilenko; Andrey Karlyshev; Vladimir Uversky; Michael L Chikindas; Vyacheslav Melnikov
Journal:  Probiotics Antimicrob Proteins       Date:  2014-12       Impact factor: 4.609

10.  Modeling the impact of Trichomonas vaginalis infection on HIV transmission in HIV-infected individuals in medical care.

Authors:  Evelyn Byrd Quinlivan; Shilpa N Patel; Catherine A Grodensky; Carol E Golin; Hsiao-Chuan Tien; Marcia M Hobbs
Journal:  Sex Transm Dis       Date:  2012-09       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.